Cancer Signal Detected with a Cancer Signal Origin for pancreas 
 

"The Galleri test found this for me really in the nick of time." 

- Roger

Roger’s Experience with the Galleri test

[Roger] I'm Roger and I live in Silicon Valley, California.

One day I was on an airplane and I read about the Galleri test in a book, that there was actually such a test that could screen for 50 different cancers.

I found Galleri online and they connected me with an independent healthcare provider that was able to provide a prescription to get the test.

The next thing you knew, they took my blood and a week later I got my results.

My telemedicine provider called me and informed me that they found a cancer signal with two predictive origins.

I remember thinking,

Please don't be pancreas.

 

And he said, one is pancreatic, gallbladder, any other stomach, esophagus, and you should do further testing.

The next day I had an MRI that showed a mass on my pancreas.

And fairly soon after that I had a CT scan, and very soon after that a biopsy.

And it was within a few weeks that I had a diagnosis of pancreas cancer.

One of the radiologists I talked to, he called me up only to tell me that I was the luckiest person he'd ever met.

Because of where the cancer was and how it was growing, I never would have had symptoms. I never would have known about this until it was at a much more advanced stage.

It's honestly been hard on my daughter.

And of course, when I got the official diagnosis, that was definitely my first thought.

This is going to be hard on my daughter.

 

But since then my condition has improved.

I'm currently no evidence of disease. So far, so good.

I thought I was doing everything a person needed to do to stay healthy.

So I had no idea that I was at risk for cancer.

That was the surprising part.

The Galleri test found this for me really in the nick of time.

 

That's how I look at it.

There would have been very little doctors could do for me if it had advanced just a little bit more.

When I first got the diagnosis, my first thought was,

I just want to stay alive long enough to see my daughter graduate high school.

 

And it looks very likely I'm going to see her graduate college and probably beyond.

Based on a clinical study of people ages 50 to 79 around 1% are expected to receive a Cancer Signal Detected result, which includes a predicted Cancer Signal Origin. After diagnostic evaluation, around 62% of these people are expected to have a confirmed cancer diagnosis. 

The overall sensitivity in study participants with liver/bile duct cancer was 93.5% (100% for stage I, 70.0% stage II, 100% stage III, 100% stage IV).

Have more questions?

Please answer the following questions to fill in the appropriate form.
 

GRAIL Customer Service 
(833) 694‑2553 
customerservice@grail.com

 

To report suspected Adverse Events or product issues, contact GRAIL Customer Service.

  1. What describes you best?

  2. What are you looking for?

  3. Fill in the form

    By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

    Billing Support

    This form is for billing questions only. If you need general customer support, please choose one of the other forms or use the chat option at the bottom of your screen.

    By submitting this form, you agree to GRAIL’s use of this information to contact you. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

    Learn more about the Galleri test - What is Galleri?

    By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

    By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

    Please login to the Provider Portal if you are already an ordering provider.

    By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

    By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

    By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

    Health System or Provider Network

    If you are a concierge, private, or group practice provider, complete this form instead.

    By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

    Do you represent a first responder or firefighter organization? Use this form instead.

    By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

    By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

    Fill out the form to download a copy of the full case study.

    This form is meant for firefighter and first responder organizations only

    By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes